Clinical Trial Update: Mesothelioma Avastin Plus Pemetrexed-cisplatin Study [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update for mesothelioma evaluating Avastin with pemetrexed-cisplatin in Phase 2 and Phase 3 completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Mesothelioma

Drugs mentioned

• Avastin (bevacizumab)
• Pemetrexed/cisplatin

Snippet

Sponsor: Intergroupe Francophone de Cancerologie Thoracique | Conditions: Mesothelioma | Phase 2, Phase 3 | Status: COMPLETED